Eric Collisson
Hematology & Oncology · Seattle, WANPI 1093731143
Payments from drug & device makers
Across 22 payments — averaging $29,753 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$318K
- Merck Kgaa$315K
- F. Hoffmann-la Roche AG$10K
- Ipsen Biopharmaceuticals, Inc$6K
- E.r. Squibb & Sons, L.L.C.$3K
- Beone Medicines USA, Inc.$2K
- plus $131 from 1 others
What the payments were for
- Consulting fees$5,06024%
- Speaking & faculty fees$5,00324%
- Travel & lodging$9,97648%
- Food & beverage$8794%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $318,496 |
| Merck Kgaa | 3 | $315,151 |
| F. Hoffmann-la Roche AG | 9 | $9,887 |
| Ipsen Biopharmaceuticals, Inc | 4 | $5,840 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,460 |
| Beone Medicines USA, Inc. | 1 | $1,600 |
| Merck | 2 | $131 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONIVYDE$5,797
- Non-Covered Product$2,074
- KEYTRUDA$110
How this compares
$654,565 in reported general payments places this provider in the 80th percentile of 349 hematology & oncology providers in Washington.
Other hematology & oncology in Seattle
- Mazyar ShadmanSeattle$36.8M
- Ryan CassadaySeattle$22.7M
- John PesandoSeattle$15.7M
- Andrew CowanSeattle$15M
- Stephen SmithSeattle$12.6M
- Stephanie LeeSeattle$11.2M
- Sara HurvitzSeattle$10.9M
- Chaitra UjjaniSeattle$10.6M
- Lawrence FongSeattle$9.7M
- Cameron TurtleSeattle$8.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.